Harris R, Whitfield T, Blanton L, Skaletsky H, Blumen K, Hyland P
bioRxiv. 2024; .
PMID: 39416170
PMC: 11482753.
DOI: 10.1101/2024.10.08.617275.
Wong R, Harrington J, Stevenson A
Australas J Dermatol. 2024; 65(8):601-609.
PMID: 39115047
PMC: 11629140.
DOI: 10.1111/ajd.14360.
Grunhagel B, Borggrewe M, Hagen S, Ziegler S, Henseling F, Glau L
iScience. 2023; 26(11):108209.
PMID: 37953956
PMC: 10637924.
DOI: 10.1016/j.isci.2023.108209.
Tsatsanis C, Elenkov A, Leijonhufvud I, Vaporidi K, Tivesten A, Giwercman A
Endocr Connect. 2023; 12(3).
PMID: 36607156
PMC: 9986405.
DOI: 10.1530/EC-22-0456.
White A, Lin A, Bickendorf X, Cavve B, Moore J, Siafarikas A
Ther Adv Endocrinol Metab. 2022; 13:20420188221139612.
PMID: 36533187
PMC: 9747891.
DOI: 10.1177/20420188221139612.
Gender-Diverse Inclusion in Immunological Research: Benefits to Science and Health.
Peckham H, Webb K, Rosser E, Butler G, Ciurtin C
Front Med (Lausanne). 2022; 9:909789.
PMID: 35911383
PMC: 9329564.
DOI: 10.3389/fmed.2022.909789.
Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
Shepherd R, Bretherton I, Pang K, Mansell T, Czajko A, Kim B
Clin Epigenetics. 2022; 14(1):24.
PMID: 35177097
PMC: 8851870.
DOI: 10.1186/s13148-022-01236-4.
Immune Sexual Dimorphism: Connecting the Dots.
Gal-Oz S, Shay T
Physiology (Bethesda). 2021; 37(2):55-68.
PMID: 34514870
PMC: 8873034.
DOI: 10.1152/physiol.00006.2021.
Research gaps in medical treatment of transgender/nonbinary people.
Safer J
J Clin Invest. 2021; 131(4).
PMID: 33586675
PMC: 7880308.
DOI: 10.1172/JCI142029.
Sexual Dimorphism in Innate Immunity: The Role of Sex Hormones and Epigenetics.
Shepherd R, Cheung A, Pang K, Saffery R, Novakovic B
Front Immunol. 2021; 11:604000.
PMID: 33584674
PMC: 7873844.
DOI: 10.3389/fimmu.2020.604000.
Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus.
Jones J, Jorgensen T
Front Immunol. 2020; 11:1271.
PMID: 32655565
PMC: 7324484.
DOI: 10.3389/fimmu.2020.01271.
Estrogen Reverses HDAC Inhibitor-Mediated Repression of and Class-Switching in Antibody and Autoantibody Responses by Downregulation of miR-26a.
Casali P, Shen T, Xu Y, Qiu Z, Chupp D, Im J
Front Immunol. 2020; 11:491.
PMID: 32265934
PMC: 7105609.
DOI: 10.3389/fimmu.2020.00491.
Medical dermatologic conditions in transgender women.
Mundluru S, Larson A
Int J Womens Dermatol. 2019; 4(4):212-215.
PMID: 30627619
PMC: 6322154.
DOI: 10.1016/j.ijwd.2018.08.008.
Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence.
Traish A, Bolanos J, Nair S, Saad F, Morgentaler A
J Clin Med. 2018; 7(12).
PMID: 30558178
PMC: 6306858.
DOI: 10.3390/jcm7120549.
Metabolic and functional changes in transgender individuals following cross-sex hormone treatment: Design and methods of the GEnder Dysphoria Treatment in Sweden (GETS) study.
Wiik A, Andersson D, Brismar T, Chanpen S, Dhejne C, Ekstrom T
Contemp Clin Trials Commun. 2018; 10:148-153.
PMID: 30023449
PMC: 6046513.
DOI: 10.1016/j.conctc.2018.04.005.
Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals.
Weinand J, Safer J
J Clin Transl Endocrinol. 2017; 2(2):55-60.
PMID: 28090436
PMC: 5226129.
DOI: 10.1016/j.jcte.2015.02.003.
Priorities for transgender medical and healthcare research.
Feldman J, Brown G, Deutsch M, Hembree W, Meyer W, Meyer-Bahlburg H
Curr Opin Endocrinol Diabetes Obes. 2016; 23(2):180-7.
PMID: 26825469
PMC: 4821501.
DOI: 10.1097/MED.0000000000000231.
Do steroid hormones have an important role on cutaneous lupus physiopathology?.
Brasileiro A, Campos S, Fidalgo A
An Bras Dermatol. 2015; 90(5):766-8.
PMID: 26560229
PMC: 4631249.
DOI: 10.1590/abd1806-4841.20154387.
CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis - from bench to bedside?.
Schiffer L, Worthmann K, Haller H, Schiffer M
Clin Exp Immunol. 2014; 179(1):85-9.
PMID: 25138065
PMC: 4260900.
DOI: 10.1111/cei.12439.